Skip to main content

Table 1 General information comparison among pregnant women

From: Evaluation of the therapeutic efficacy of different doses of LT4 in pregnant women with high-normal TSH levels and TPOAb positivity in the first half of pregnancy

Parameter

G0 (n = 122)

G25 (n = 69)

G50 (n = 58)

P

Age (years)

30.00(27.00–33.00)

31.00(29.00–34.00)

31.00(28.00–32.00)

0.250

BMI (kg/m2)

21.39(19.36–23.49)

21.88(20.32–23.78)

21.64(20.21–23.55)

0.308

Gestational weeks

11.65(7.40–13.50)

8.57(6.43–12.43)

11.79(7.40-13.47)

0.084

Adverse obstetric history

0(0–0)

0(0–1)

0(0–0)

0.059

Pregnancy

2(1–2)

2(1–3)

2(1–2)

0.355

Parity

0(0–1)

0(0–1)

0(0–1)

0.920

FT4 (pmol/L)

15.00(13.90-16.43)

15.10(13.60–16.80)

14.85(13.20-16.83)

0.529

TSH (mIU/L)

3.02(2.77–3.41)

3.04(2.80–3.51)

3.17(2.85–3.67)

0.171

TPOAb (IU/mL)

125.00(72.08-251.25)

169.00(85.85–294.50)

150.00(85.45-279.25)

0.184

TC (mmol/L)

4.63 ± 0.68

4.73 ± 0.50

4.56 ± 0.54

0.288

TG (mmol/L)

1.34 ± 0.41

1.44 ± 0.49

1.37 ± 0.33

0.263

HDL (mmol/L)

1.75 ± 0.34

1.82 ± 0.40

1.71 ± 0.37

0.199

LDL (mmol/L)

2.53 ± 0.63

2.68 ± 0.55

2.52 ± 0.69

0.243

  1. Numerical data are exhibited as either the median along with its interquartile range or as the mean along with the standard deviation. All comparisons were corrected using Bonferroni correction